… patients with atherosclerotic vascular disease is more effective than aspirin in reducing the
combined risk of ischaemic … of clopidogrel is at least as good as that of medium-dose aspirin. …

… 17%) in the aspirin group. Interpretation Long-term administration … patients with atherosclerotic
vascular disease is more effective than aspirin in reducing the combined risk of ischaemic …

… events. We have studied the effect of low-dose aspirin in patients with myocardial ischaemia
… (though patients might have had symptomatic ischaemia at other times) or symptomatic. …

… Aspirin is widely used for the prevention of recurrent stroke in patients with transient ischaemic
attack (TIA) and ischaemic … Clopidogrel and the combination of aspirin and extended-…

… In a further analysis we pooled data from trials of aspirin versus control in which patients …
effect of aspirin on risk of recurrent ischaemic stroke and how this differs by severity at baseline. …

… patients with atherosclerotic vascular disease is more effective than aspirin in reducing the
combined risk of ischaemic … of clopidogrel is at least as good as that of medium-dose aspirin. …

… than aspirin, the FDA did not approve aspirin for patients with … aspirin exclusively in PAD
patients were found [6]. Consequently, the currently widespread practice of prescribing aspirin …

… receptor antagonist terutroban with aspirin in the prevention of cerebral and cardiovascular
ischaemic events in patients with a recent non-cardioembolic cerebral ischaemic event. …

… of the United Kingdom transient ischaemic attack (UK-TIA) trial of long-term treatment with
aspirin in 2435 patients with a transient ischaemic attack or minor ischaemic stroke.' The data …

… Early administration of intravenous aspirin in patients with acute ischaemic stroke treated
with alteplase does not improve outcome at 3 months and increases the risk of SICH. The …